dimtelzo 240 mg zarnās šķīstošās cietās kapsulas
sandoz d.d., slovenia - dimetilfumarāts - zarnās šķīstošā kapsula, cietā - 240 mg
brimica genuair
covis pharma europe b.v. - formoterol fumarate dihydrate, aclidinium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - brimica genuair ir indicēts kā uzturējoša bronhodilatatora terapija gaisa plūsmas obstrukcijai un simptomu atvieglošanai pieaugušiem pacientiem ar hronisku obstruktīvu plaušu slimību (hops).
bisoprolol vitabalans 10 mg tabletes
vitabalans oy, finland - bisoprolola hemifumarāts - tablete - 10 mg
bisoprolol vitabalans 5 mg tabletes
vitabalans oy, finland - bisoprolola hemifumarāts - tablete - 5 mg
lv tiamulin oral 125 mg/ml šķīdums lietošanai ar dzeramo ūdeni
uab "interchemie werken "de adelaar" lt", lietuva - tiamulīns ūdeņraža fumarate - šķīdums lietošanai ar dzeramo ūdeni - 125 mg/ml - cūkas; tītari; vistas
tiamvet 100 100 mg/g premikss ārstnieciskās barības pagatavošanai
ceva sante animale., francija - tiamulīns ūdeņraža fumarate - premikss ārstnieciskās barības pagatavošanai - 100 mg/g - cūkas
duaklir genuair
covis pharma europe b.v. - aclidinium bromīds, formoterol fumarate dihidrāts - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - duakliru genuair ir indicēts kā uzturēšanas bronhodilatatora terapija simptomu mazināšanai pieaugušiem pacientiem ar hronisku obstruktīvu plaušu slimību (hops).
vemlidy
gilead sciences ireland uc - tenofovira alafenamīda fumarāts - b hepatīts - pretvīrusu līdzekļi sistēmiskai lietošanai - vemlidy is indicated for the treatment of chronic hepatitis b (chb) in adults and paediatric patients 6 years of age and older weighing at least 25 kg (see section 5.
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - plaušu slimība, hroniska obstruktīva - formoterol un glycopyrronium bromide - bevespi aerosphere ir norādīts, kā tehniskās apkopes bronchodilator ārstēšana, lai mazinātu simptomus pieaugušiem pacientiem ar hronisku obstruktīvu plaušu slimību (hops).